Literature DB >> 26446421

Resolution of Chlamydia trachomatis Infection Is Associated with a Distinct T Cell Response Profile.

Michele D Picard1, Jean-Luc Bodmer2, Todd M Gierahn2, Alexander Lee2, Jessica Price2, Kenya Cohane2, Veronica Clemens2, Victoria L DeVault2, Galina Gurok2, Robert Kohberger3, Darren E Higgins4, George R Siber2, Jessica Baker Flechtner2, William M Geisler5.   

Abstract

Chlamydia trachomatis is the causative agent of the most frequently reported bacterial sexually transmitted infection, the total burden of which is underestimated due to the asymptomatic nature of the infection. Untreated C. trachomatis infections can cause significant morbidities, including pelvic inflammatory disease and tubal factor infertility (TFI). The human immune response against C. trachomatis, an obligate intracellular bacterium, is poorly characterized but is thought to rely on cell-mediated immunity, with CD4(+) and CD8(+) T cells implicated in protection. In this report, we present immune profiling data of subjects enrolled in a multicenter study of C. trachomatis genital infection. CD4(+) and CD8(+) T cells from subjects grouped into disease-specific cohorts were screened using a C. trachomatis proteomic library to identify the antigen specificities of recall T cell responses after natural exposure by measuring interferon gamma (IFN-γ) levels. We identified specific T cell responses associated with the resolution of infection, including unique antigens identified in subjects who spontaneously cleared infection and different antigens associated with C. trachomatis-related sequelae, such as TFI. These data suggest that novel and unique C. trachomatis T cell antigens identified in individuals with effective immune responses can be considered as targets for vaccine development, and by excluding antigens associated with deleterious sequelae, immune-mediated pathologies may be circumvented.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26446421      PMCID: PMC4622104          DOI: 10.1128/CVI.00247-15

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  55 in total

1.  Diversity of the Chlamydia trachomatis common plasmid in biovars with different pathogenicity.

Authors:  M Comanducci; S Ricci; R Cevenini; G Ratti
Journal:  Plasmid       Date:  1990-03       Impact factor: 3.466

2.  Chlamydia trachomatis-associated ectopic pregnancy: serologic and histologic correlates.

Authors:  R C Brunham; R Peeling; I Maclean; M L Kosseim; M Paraskevas
Journal:  J Infect Dis       Date:  1992-06       Impact factor: 5.226

3.  Trachoma vaccine field trials in The Gambia.

Authors:  S Sowa; J Sowa; L H Collier; W A Blyth
Journal:  J Hyg (Lond)       Date:  1969-12

Review 4.  T cell-dependent B cell activation.

Authors:  D C Parker
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

5.  Differential human serologic response to two 60,000 molecular weight Chlamydia trachomatis antigens.

Authors:  E A Wagar; J Schachter; P Bavoil; R S Stephens
Journal:  J Infect Dis       Date:  1990-10       Impact factor: 5.226

6.  Immunity to murine Chlamydia trachomatis genital tract reinfection involves B cells and CD4(+) T cells but not CD8(+) T cells.

Authors:  S G Morrison; H Su; H D Caldwell; R P Morrison
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

7.  Identification of novel virus-specific antigens by CD4⁺ and CD8⁺ T cells from asymptomatic HSV-2 seropositive and seronegative donors.

Authors:  Deborah Long; Mojca Skoberne; Todd M Gierahn; Shane Larson; Jessica A Price; Veronica Clemens; Amy E Baccari; Kenya P Cohane; Danielle Garvie; George R Siber; Jessica B Flechtner
Journal:  Virology       Date:  2014-08-09       Impact factor: 3.616

8.  Serologic responses of infertile women to the 60-kd chlamydial heat shock protein (hsp60).

Authors:  J N Arno; Y Yuan; R E Cleary; R P Morrison
Journal:  Fertil Steril       Date:  1995-10       Impact factor: 7.329

9.  Association between antibody to the chlamydial heat-shock protein and tubal infertility.

Authors:  B Toye; C Laferrière; P Claman; P Jessamine; R Peeling
Journal:  J Infect Dis       Date:  1993-11       Impact factor: 5.226

10.  Proliferative response to conserved epitopes of the Chlamydia trachomatis and human 60-kilodalton heat-shock proteins by lymphocytes from women with salpingitis.

Authors:  S S Witkin; J Jeremias; M Toth; W J Ledger
Journal:  Am J Obstet Gynecol       Date:  1994-08       Impact factor: 8.661

View more
  10 in total

1.  Identification of Chlamydia trachomatis Antigens Recognized by T Cells From Highly Exposed Women Who Limit or Resist Genital Tract Infection.

Authors:  Ali N Russell; Xiaojing Zheng; Catherine M O'Connell; Harold C Wiesenfeld; Sharon L Hillier; Brandie D Taylor; Michelle D Picard; Jessica B Flechtner; Wujuan Zhong; Lauren C Frazer; Toni Darville
Journal:  J Infect Dis       Date:  2016-10-12       Impact factor: 5.226

Review 2.  Update on Chlamydia trachomatis Vaccinology.

Authors:  Luis M de la Maza; Guangming Zhong; Robert C Brunham
Journal:  Clin Vaccine Immunol       Date:  2017-04-05

3.  B Cell Presentation of Chlamydia Antigen Selects Out Protective CD4γ13 T Cells: Implications for Genital Tract Tissue-Resident Memory Lymphocyte Clusters.

Authors:  Raymond M Johnson; Hong Yu; Norma Olivares Strank; Karuna Karunakaran; Ying Zhu; Robert C Brunham
Journal:  Infect Immun       Date:  2018-01-22       Impact factor: 3.441

4.  Chlamydial Type III Secretion System Needle Protein Induces Protective Immunity against Chlamydia muridarum Intravaginal Infection.

Authors:  Ekaterina A Koroleva; Natalie V Kobets; Dmitrii N Shcherbinin; Naylia A Zigangirova; Maxim M Shmarov; Amir I Tukhvatulin; Denis Y Logunov; Boris S Naroditsky; Alexander L Gintsburg
Journal:  Biomed Res Int       Date:  2017-03-26       Impact factor: 3.411

5.  A flow cytometry-based assay to determine the phagocytic activity of both clinical and nonclinical antibody samples against Chlamydia trachomatis.

Authors:  Marco Grasse; Ida Rosenkrands; Anja Olsen; Frank Follmann; Jes Dietrich
Journal:  Cytometry A       Date:  2018-03-07       Impact factor: 4.355

6.  Risk of gastroschisis with maternal genitourinary infections: the US National birth defects prevention study 1997-2011.

Authors:  Marcia L Feldkamp; Kathryn E Arnold; Sergey Krikov; Jennita Reefhuis; Lynn M Almli; Cynthia A Moore; Lorenzo D Botto
Journal:  BMJ Open       Date:  2019-03-30       Impact factor: 2.692

Review 7.  Future prospects for new vaccines against sexually transmitted infections.

Authors:  Sami L Gottlieb; Christine Johnston
Journal:  Curr Opin Infect Dis       Date:  2017-02       Impact factor: 4.915

8.  The relative contribution of causal factors in the transition from infection to clinical chlamydial disease.

Authors:  Bonnie L Quigley; Scott Carver; Jon Hanger; Miranda E Vidgen; Peter Timms
Journal:  Sci Rep       Date:  2018-06-11       Impact factor: 4.379

9.  Cellular Basis for the Enhanced Efficacy of the Fms-Like Tyrosine Kinase 3 Ligand (FL) Adjuvanted VCG-Based Chlamydia abortus Vaccine.

Authors:  Shakyra Richardson; Fnu Medhavi; Tayhlor Tanner; Stephanie Lundy; Yusuf Omosun; Joseph U Igietseme; Darin Carroll; Francis O Eko
Journal:  Front Immunol       Date:  2021-06-24       Impact factor: 7.561

10.  Antigen-specific memory and naïve CD4+ T cells following secondary Chlamydia trachomatis infection.

Authors:  Jennifer D Helble; Alexander O Mann; Michael N Starnbach
Journal:  PLoS One       Date:  2020-10-22       Impact factor: 3.752

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.